Live Breaking News & Updates on National Cancer Center Hospital East

Stay updated with breaking news from National cancer center hospital east. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Claudin-18.2 Emerges as a Novel Therapeutic Target in GI Malignancies

CLDN18.2 has become a promising target for the treatment of patients with digestive malignancies, such as gastric cancer, gastroesophageal junction cancer, esophageal cancer, and pancreatic cancer, because of its limited expression in healthy tissues and abnormal overexpression in a range of malignancies. ....

United States , Keymed Biosciences , Kohei Shitara , American Society Of Clinical Oncology , Transcenta Holding , University Of Texas Md Anderson Cancer Center , Astellas Pharma Inc , Malignant Cells , Clinical Oncology , Gastrointestinal Cancers Symposium , Gastrointestinal Oncology , National Cancer Center Hospital East , Cancer Center , Next Steps , Holding Limited ,